共 84 条
[1]
Anonymous J(1996)A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE steering committee Lancet 348 1329-1339
[2]
Belch A(2008)The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease BMJ (Clin Res Ed) 337 1840-4358
[3]
Maccuish I(2007)Circulating tissue factor procoagulant activity and thrombin generation in patients with type 2 diabetes: effects of insulin and glucose J Clin Endocrinol Metab 92 4352-12
[4]
Campbell G(2010)Tissue factor and cardiovascular disease Circ J 74 3-1860
[5]
Boden VR(2009)Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials Lancet (London, England) 373 1849-974
[6]
Vaidyula C(2000)Endothelial dysfunction in diabetes Br J Pharmacol 130 963-6060
[7]
Homko A(2012)Biological efficacy of twice daily aspirin in type 2 diabetic patients with coronary artery disease Am Heart J 164 600-2539
[8]
Breitenstein FC(2008)Von Willebrand factor, type 2 diabetes mellitus, and risk of cardiovascular disease: the framingham offspring study Circulation 118 2533-2585
[9]
Tanner TF(2009)Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study Circulation 120 2577-176
[10]
Lüscher A(2004)Mean platelet volume in Type 2 diabetic patients J Diabetes Complicat 18 173-33